---
title: "Waystar Q2 2026 revenue up 18% to $320M, adjusted EBITDA margin 43%"
description: "Waystar reported second-quarter 2026 financial results, citing another quarter of profitable growth. Revenue reached $320 million, up 18% year over year, according to the company."
canonical_url: https://clinicalterminal.com/article/103693848
section: vendors
byline: The Desk · AI-assisted
date_published: 2026-08-02T05:36:41.377Z
date_label: August 2, 2026
image: https://firebasestorage.googleapis.com/v0/b/clinical-ai-design.firebasestorage.app/o/desk-heroes%2FKBhSTnUyN3lE6M0Ofwl4%2Fhero_f325a3398820_w1920.jpg?alt=media
source: https://clinicalterminal.com
---

# Waystar Q2 2026 revenue up 18% to $320M, adjusted EBITDA margin 43%

*[Waystar](https://app.clinicalterminal.com/company/100058) reported second-quarter 2026 financial results, citing another quarter of profitable growth. Revenue reached $320 million, up 18% year over year, according to the company.*

Adjusted EBITDA came in at $137 million, representing an adjusted EBITDA margin of 43%. Waystar said it remains focused on delivering client outcomes through innovation across its AI-powered platform.

The company pointed to its earnings call replay for further details on the results.

## Sources

- [Waystar](https://www.linkedin.com/posts/waystar_earningscall-revenuecycle-ai-activity-7488964496695185408-Yvsl)

---
Canonical article: https://clinicalterminal.com/article/103693848  
Entity profiles referenced above resolve to https://app.clinicalterminal.com.